Correlation Between Vitamin D3, Atherogenic Indices of Plasma and Cardiometabolic Biomarkers in Diabetic Patients
Biomedical Current Insights · 2026
DOI: 10.63626/tpp78y24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Current Insights, 2026. Verfasst von Urooj Ata und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiometabolic disease is a cluster of interconnected cardiovascular and metabolic disorders. These include obesity, insulin resistance, hypertension, heart disease and type 2 diabetes. In this study, focus was to identify correlation between serum vitamin D3 levels along with Atherogenic Indices of Plasma (AIP) and cardio metabolic biomarkers with a purpose to assess as potential indicators of the cardio metabolic disease risk in the type 2 diabetes mellitus (T2DM) patients.
Methods
The study was a cross-sectional investigation conducted in a total of 105 patients with diabetes mellitus in Islamabad region of Pakistan. Participants were selected randomly with an age range of 45-79 years. The clinical data sets were analyzed using Pearson correlation, Kolmogorov-Smirnov and independent t-test.
Results
Vitamin D3 showed a strong inverse correlation with the total cholesterol (r=-0.483, p
Zitieren
APA
Ata, U., Malik, S. T., Raza, A., Raja, N., & Qasim, U. (2026). Correlation Between Vitamin D3, Atherogenic Indices of Plasma and Cardiometabolic Biomarkers in Diabetic Patients. Biomedical Current Insights. https://doi.org/10.63626/tpp78y24
Vancouver
Ata U, Malik ST, Raza A, Raja N, Qasim U. Correlation Between Vitamin D3, Atherogenic Indices of Plasma and Cardiometabolic Biomarkers in Diabetic Patients. Biomedical Current Insights. 2026. doi:10.63626/tpp78y24
BibTeX
@article{Ata2026,
author = {Ata, Urooj and Malik, Sadaf Tahir and Raza, Ali and Raja, Noor-ul-Huda and Qasim, Umair},
title = {Correlation Between Vitamin D3, Atherogenic Indices of Plasma and Cardiometabolic Biomarkers in Diabetic Patients},
journal = {Biomedical Current Insights},
year = {2026},
doi = {10.63626/tpp78y24}
}
EUVIMED